SOUTH SAN FRANCISCO, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced an upcoming presentation at CMR 2024 taking place online and in person in ...
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data at CMR 2024 demonstrating favorable effects on cardiac structure, ...
NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata Clinical Data ...
Running a global franchise organization presents some specific challenges when it comes to hiring and retaining staff with the right skills. For Inter IKEA Group, the franchise arm of IKEA, it meant ...
Cytokinetics Presents Positive Aficamten Data for Obstructive HCM at European Heart Failure Congress
Cytokinetics Incorporated (NASDAQ:CYTK) is one of the most active stocks to buy according to analysts. Earlier in May, Cytokinetics announced the presentation of additional data regarding aficamten at ...
BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that members of the management team will hold a live ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback